In addition to its originally proposed roles in innate immunity, available evidence suggests that CARD9 plays novel regulatory roles in the development of glucose intolerance and insulin resistance in animal models of diet-induced obesity, glucose intolerance, and insulin resistance. This evidence concerns the gene CARD9 and Insulin resistance.